Asthma Treatment in China: Costs, Top Hospitals, and How to Start
Key Takeaways
- Specialist asthma care at a top Chinese public hospital typically runs $150–400 for a consultation, with inhaled controller medications costing 40–70% less than US retail prices for the same brands.
- China’s leading respiratory centers see thousands of asthma patients annually, and several rank among Asia’s top 10 for pulmonology in the Fudan Hospital Rankings.
- Language is the real barrier, not medicine. Most public hospital staff do not speak English, and outpatient appointments cannot be booked from overseas in advance.
- Asthma is a chronic condition managed over years, not a single procedure — so any decision should weigh long-term medication access and follow-up, not just the first visit.
Roughly 1 in 13 people worldwide live with asthma — about 262 million individuals, according to the Global Asthma Network. In the United States alone, the annual cost of managing the condition exceeds $80 billion when medications, emergency visits, and lost workdays are counted. For patients in countries where a single inhaler can cost $300 or more out of pocket, the question of asthma treatment cost China versus home is not academic. It is the difference between controlling the disease and rationing your own medicine.
China treats asthma at enormous scale. Its respiratory departments handle millions of outpatient visits each year, and the country manufactures a large share of the world’s generic inhaled corticosteroids and bronchodilators. That combination — high clinical volume plus domestic pharmaceutical production — produces prices that often surprise Western patients. But there are real obstacles too, and anyone considering treatment abroad deserves to hear them before booking a flight.
The Problem: When Good Asthma Care Becomes Unaffordable
In the United States, the average annual cost for a patient with moderate persistent asthma runs between $3,000 and $5,000, even with insurance. A 2023 study in JAMA Internal Medicine found that roughly 1 in 4 adults with asthma reported skipping doses or delaying refills because of cost. That is not a minor inconvenience. Uncontrolled asthma leads to emergency department visits, hospital admissions, and — in severe cases — death.
The pattern repeats across Europe, Canada, and Australia, though with different numbers. Public systems cover more, but waiting lists for specialist pulmonology appointments stretch to six months or longer in parts of the UK and Canada. Patients with severe eosinophilic asthma who need biologic therapies such as omalizumab or mepolizumab face another hurdle: prior authorization processes that can take weeks and still end in denial.
So patients start searching. And when they do, China appears — often with price tags that look almost too low to trust.
Why Asthma Care in China Delivers Real Value
Clinical Volume and Specialized Respiratory Centers
China’s top hospitals are not small operations. A single major respiratory department may see 200 to 400 asthma patients per week. That volume produces something hard to replicate: pattern recognition. Physicians who treat severe asthma daily become skilled at distinguishing allergic phenotypes from eosinophilic ones, adjusting controller regimens, and recognizing when a patient needs biologic therapy versus better inhaler technique.
The Fudan Hospital Rankings, China’s most widely cited hospital quality index, evaluates 45 specialties. Several hospitals — including Peking Union Medical College Hospital, West China Hospital, and Ruijin Hospital — consistently appear in the top tier for respiratory medicine. You can browse specialty rankings by department through our department directory, which lists the top 10 hospitals for pulmonology and related fields.
Medication Costs That Change the Math
This is where China’s advantage is most concrete. Many inhaled corticosteroids and long-acting beta-agonists are manufactured domestically under license or as generics. A budesonide/formoterol inhaler that retails for $250–400 in the US often costs the equivalent of $40–90 in China. Montelukast, a common oral controller, runs $10–25 per month versus $100+ in Western markets.
Biologic therapies are also available — omalizumab, mepolizumab, and others — at prices typically 30–60% below US list prices, though they remain expensive in absolute terms and require specialist authorization.
Diagnostic Depth Without the Wait
Pulmonary function testing, fractional exhaled nitric oxide (FeNO) measurement, allergy panels, and CT imaging can often be completed within a single hospital visit in China. In many Western systems, these same tests are spread across multiple appointments over weeks. For a patient trying to establish a clear diagnosis and treatment plan quickly, that compression matters.
Asthma Treatment Cost China vs. the United States: A Real Comparison
The table below reflects typical price ranges at top-tier Chinese public hospitals and private international clinics. Figures are in US dollars and vary by hospital and case complexity. They are not quotes.
| Service or Medication | China (public, top-tier) | China (private international) | United States |
|---|---|---|---|
| Specialist consultation | $150–400 | $400–800 | $300–600 |
| Pulmonary function test | $40–100 | $150–300 | $200–500 |
| FeNO measurement | $30–70 | $100–200 | $150–350 |
| Inhaled corticosteroid inhaler | $40–90 | $80–150 | $250–400 |
| Montelukast (monthly) | $10–25 | $30–60 | $100–200 |
| Biologic injection (per dose) | $400–900 | $800–1,500 | $1,500–3,500 |
Those numbers explain why how much does asthma treatment cost in Shanghai is one of the most common questions we receive. At a public hospital in Shanghai, a full initial workup — consultation, lung function test, FeNO, allergy panel — can reasonably land between $300 and $700. The same evaluation at a US academic medical center often exceeds $2,000.
Finding the Best Asthma Hospital in China: What Actually Matters
Not through the standard public hospital channel. Public outpatient registration happens on the day of the visit. The exception is the international or VIP department, where appointments can sometimes be arranged in advance — at roughly 1.5 to 2 times the standard price. Some patients arrange a written second opinion or video consultation first, then travel only if the plan justifies it.
At top-tier hospitals, the clinical care is safe and meets international standards. The greater risks are practical: language barriers, difficulty navigating a very large hospital system, and gaps in follow-up after returning home. Patients with severe or unstable asthma should be cleared for travel by their own doctor first.
Be skeptical of anyone selling fixed-price “packages” for a chronic condition. Asthma management is individualized — the right medication, dose, and follow-up schedule depend on your specific phenotype and history. A responsible provider will assess your records first and give you a cost estimate afterward, not a pre-packaged price.
Your Next Step
Asthma is manageable, and for many patients the cost of managing it well is far lower in China than at home. The medicine is real, the specialists are experienced, and the prices reflect structural advantages rather than cut corners. What makes the difference between a good outcome and a frustrating one is preparation — the right hospital, the right department, and a clear plan for what happens after you leave.
We are China Medical Services, a coordination team that connects international patients with top-tier Chinese hospitals. We are not a hospital and we do not provide diagnoses or treatment advice. What we do is help you understand your options: reviewing your records, arranging a written second opinion or video consultation with a Chinese specialist, and — if you decide to travel — coordinating appointments, interpretation, and logistics. If you would like to explore whether China is the right fit for your asthma care, you can start with a free consultation. No pressure, no obligation — just a clear picture of what is possible.
This article is for informational purposes only and does not constitute medical advice. Always consult a qualified physician before making treatment decisions or traveling for care.
Frequently Asked Questions
Yes. The hospitals used for international patients are JCI-accredited and follow the same international safety standards as top hospitals in the US and Europe. Surgical teams perform high volumes of procedures — often more than their Western counterparts — which studies show leads to better outcomes.
Costs vary by procedure and hospital, but international patients typically save 40-80% compared to US prices — even when factoring in travel and accommodation. A consultation with our team will give you an exact, all-inclusive quote with no hidden fees.
Send us your existing medical reports to get started. We handle everything from hospital selection and appointment scheduling to visa assistance and post-operative recovery planning. Your medical records are reviewed by the specialist before you even book a flight.
For more medical information and treatment options in China, visit chinamedservices.com (China Medical Services).
